Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Adam S Cheifetz

Showing results (61-70 of 203) with videos related to

Pageof 21
Sort By:
Inflammatory Bowel Diseases|January 16, 2015
Biologic concentration testing in inflammatory bowel diseaseByron P Vaughn, William J Sandborn, Adam S Cheifetz
Gastroenterology Clinics of North America|April 17, 2012
Patient-specific approach to combination versus monotherapy with the use of antitumor necrosis factor α agents for inflammatory bowel diseaseShane M Devlin, Adam S Cheifetz, Corey A Siegel, et al.
Gastrointestinal Endoscopy|April 19, 2011
Capsule endoscopy for small-bowel evaluation in Crohn's diseaseGlen A Doherty, Alan C Moss, Adam S Cheifetz
The American Journal of Gastroenterology|August 6, 2014
Colonoscopy is appropriately utilized in most cases following a fair bowel prepJoseph D Feuerstein, Daniel A Leffler, Adam S Cheifetz
The New England Journal of Medicine|December 14, 2012
How physicians interpret research funding disclosuresJoseph D Feuerstein, Daniel A Leffler, Adam S Cheifetz
The American Journal of Gastroenterology|November 14, 2012
Impact of antibodies to infliximab on clinical outcomes and serum infliximab levels in patients with inflammatory bowel disease (IBD): a meta-analysisKavinderjit S Nanda, Adam S Cheifetz, Alan C Moss
Digestive Diseases and Sciences|August 14, 2019
Bone of Contention: Helicobacter pylori and Osteoporosis-Is There an Association?Konstantinos Papamichael, Garyfallia Papaioannou, Marcy A Cheifetz, et al.
Digestive Diseases and Sciences|July 15, 2018
Maintenance Adalimumab Concentrations Are Associated with Biochemical, Endoscopic, and Histologic Remission in Inflammatory Bowel DiseaseAnna Juncadella, Konstantinos Papamichael, Byron P Vaughn, et al.
Gastroenterology|October 17, 2016
Complementary and Alternative Medicines Used by Patients With Inflammatory Bowel DiseasesAdam S Cheifetz, Robert Gianotti, Raphael Luber, et al.
Inflammatory Bowel Diseases|December 28, 2018
The Treatment of Inflammatory Bowel Disease in Patients With a History of MalignancySteven C Lin, Alex Goldowsky, Konstantinos Papamichael, et al.
Pageof 21

Showing results (61-70 of 203) with videos related to

Sort By:
Pageof 21
Inflammatory Bowel Diseases|January 16, 2015
Biologic concentration testing in inflammatory bowel diseaseByron P Vaughn, William J Sandborn, Adam S Cheifetz
Gastroenterology Clinics of North America|April 17, 2012
Patient-specific approach to combination versus monotherapy with the use of antitumor necrosis factor α agents for inflammatory bowel diseaseShane M Devlin, Adam S Cheifetz, Corey A Siegel, et al.
Gastrointestinal Endoscopy|April 19, 2011
Capsule endoscopy for small-bowel evaluation in Crohn's diseaseGlen A Doherty, Alan C Moss, Adam S Cheifetz
The American Journal of Gastroenterology|August 6, 2014
Colonoscopy is appropriately utilized in most cases following a fair bowel prepJoseph D Feuerstein, Daniel A Leffler, Adam S Cheifetz
The New England Journal of Medicine|December 14, 2012
How physicians interpret research funding disclosuresJoseph D Feuerstein, Daniel A Leffler, Adam S Cheifetz
The American Journal of Gastroenterology|November 14, 2012
Impact of antibodies to infliximab on clinical outcomes and serum infliximab levels in patients with inflammatory bowel disease (IBD): a meta-analysisKavinderjit S Nanda, Adam S Cheifetz, Alan C Moss
Digestive Diseases and Sciences|August 14, 2019
Bone of Contention: Helicobacter pylori and Osteoporosis-Is There an Association?Konstantinos Papamichael, Garyfallia Papaioannou, Marcy A Cheifetz, et al.
Digestive Diseases and Sciences|July 15, 2018
Maintenance Adalimumab Concentrations Are Associated with Biochemical, Endoscopic, and Histologic Remission in Inflammatory Bowel DiseaseAnna Juncadella, Konstantinos Papamichael, Byron P Vaughn, et al.
Gastroenterology|October 17, 2016
Complementary and Alternative Medicines Used by Patients With Inflammatory Bowel DiseasesAdam S Cheifetz, Robert Gianotti, Raphael Luber, et al.
Inflammatory Bowel Diseases|December 28, 2018
The Treatment of Inflammatory Bowel Disease in Patients With a History of MalignancySteven C Lin, Alex Goldowsky, Konstantinos Papamichael, et al.
Pageof 21